Notice: This company has been marked as potentially delisted and may not be actively trading. Atreca (BCEL) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Atreca Inc Class A (OTC:BCEL) Stock Quotes, Forecast and News SummaryOctober 8, 2024 | benzinga.comBicycle Therapeutics Is Looking Increasingly AttractiveAugust 20, 2024 | seekingalpha.comAtreca, Inc. (BCEL) Stock Price, News, Quote & History - Yahoo FinanceApril 23, 2024 | ca.finance.yahoo.comAtreca, Inc. (0C1.MU)April 21, 2024 | nz.finance.yahoo.comAtreca Inc. Cl AFebruary 18, 2024 | wsj.comAtreca Stock (NASDAQ:BCEL), Short Interest ReportFebruary 15, 2024 | benzinga.comAtreca Inc Announces Executive Departures and Consulting AgreementsFebruary 7, 2024 | msn.comImmunome to buy assets from California biotech companyDecember 29, 2023 | bizjournals.comBCEL Stock Alert: Halper Sadeh LLC Is Investigating Atreca, Inc.December 26, 2023 | tmcnet.comTrading was temporarily halted for "BCEL" at 08:12 AM with a stated reason of "News pending."December 26, 2023 | marketbeat.comAtreca Inc.December 21, 2023 | thestreet.comAtreca Stock (NASDAQ:BCEL) Dividends: History, Yield and DatesDecember 11, 2023 | benzinga.comAtreca Inc Class A BCELNovember 16, 2023 | morningstar.comAtreca to Cut About 40% of WorkforceNovember 14, 2023 | marketwatch.comAtreca Reports Third Quarter 2023 Financial Results and Announces Further Reorganization to Support Exploration of Strategic AlternativesNovember 14, 2023 | finance.yahoo.comAtreca Inc (BCEL)November 2, 2023 | es.investing.comBAKER BROS. ADVISORS LP Reduces Stake in Atreca IncOctober 24, 2023 | finance.yahoo.comWhat's Going On With Atreca Inc Stock?October 12, 2023 | benzinga.comMid-Peninsula building rode biotech's boom. Now it's showing how to survive the bustOctober 12, 2023 | bizjournals.comAtreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb CrossSeptember 21, 2023 | finance.yahoo.comHC Wainwright & Co. Downgrades Atreca Inc - (BCEL)August 11, 2023 | msn.comStifel Downgrades Atreca Inc - (BCEL)August 11, 2023 | msn.comAtreca Reports Second Quarter 2023 Financial Results and Announces Corporate RestructuringAugust 11, 2023 | finance.yahoo.comAtreca Inc - (BCEL) Price Target Increased by 11.89% to 10.20August 2, 2023 | msn.comAtreca Approaches A Major Go/No-Go DecisionJune 20, 2023 | msn.comStifel Nicolaus Reaffirms Their Buy Rating on Atreca (BCEL)June 6, 2023 | markets.businessinsider.comHC Wainwright & Co. Reiterates Atreca Inc - (BCEL) Buy RecommendationJune 5, 2023 | msn.comAtreca Presents Data from Ongoing Phase 1b Study of ATRC-101 in Patients with Select Advanced Solid Tumors during Oral Abstract Session at the ASCO 2023 Annual MeetingJune 5, 2023 | finance.yahoo.comAtreca (BCEL) Gets a Buy from H.C. WainwrightJune 5, 2023 | markets.businessinsider.comAtreca (NASDAQ: BCEL)June 2, 2023 | fool.comStifel Nicolaus Sticks to Their Buy Rating for Atreca (BCEL)May 30, 2023 | markets.businessinsider.comAtreca, Inc. (BCEL) Interactive Stock Chart - Yahoo FinanceMay 17, 2023 | ca.finance.yahoo.comAtreca, Inc. (BCEL) Stock Historical Prices & Data - Yahoo FinanceMay 14, 2023 | ca.finance.yahoo.comHC Wainwright & Co. Reiterates Atreca, Inc. (BCEL) Buy RecommendationMay 12, 2023 | msn.comStifel Maintains Atreca, Inc. (BCEL) Buy RecommendationMay 11, 2023 | msn.comAtreca, Inc.: Atreca Reports First Quarter 2023 Financial Results and Recent Corporate DevelopmentsMay 11, 2023 | finanznachrichten.deAnalysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Atreca (BCEL) and Oscar Health (OSCR)May 11, 2023 | markets.businessinsider.comAtreca Reports First Quarter 2023 Financial Results and Recent Corporate DevelopmentsMay 10, 2023 | finance.yahoo.comAtreca Announces Oral Presentation of ATRC-101 Phase 1b Study Data at ASCO 2023 Annual MeetingApril 26, 2023 | finance.yahoo.comAtreca to Participate in the Canaccord Genuity Horizons in Oncology Virtual ConferenceApril 13, 2023 | finance.yahoo.comHere's Why Atreca, Inc. (BCEL) Is a Great 'Buy the Bottom' Stock NowApril 6, 2023 | finance.yahoo.comAre Medical Stocks Lagging ASLAN Pharmaceuticals (ASLN) This Year?April 5, 2023 | finance.yahoo.comAtreca to Host Fourth Quarter and Year End 2022 Conference Call and Webcast on March 29, 2023March 23, 2023 | finance.yahoo.comAtreca (BCEL) Earnings Dates & ReportsMarch 21, 2023 | investing.comAtreca to Participate at Cowen’s 43rd Annual Health Care ConferenceMarch 1, 2023 | finance.yahoo.comAtreca and Xencor to Develop T Cell Engaging Bispecific Antibody Directed Against Novel Solid Tumor TargetFebruary 6, 2023 | finance.yahoo.comAtreca Appoints Philippe Bishop, MD as Chief Medical OfficerJanuary 9, 2023 | finance.yahoo.comAtreca Reports Third Quarter 2022 Financial Results and Provides Pipeline UpdateNovember 10, 2022 | finance.yahoo.comAtreca Announces Poster Presentations at Society for Immunotherapy of Cancer (SITC) Annual Meeting - GlobeNewswireOctober 5, 2022 | globenewswire.comAtreca Announces Poster Presentations at Society for Immunotherapy of Cancer (SITC) Annual MeetingOctober 5, 2022 | finance.yahoo.com Remove Ads Get Atreca News Delivered to You Automatically Sign up to receive the latest news and ratings for BCEL and its competitors with MarketBeat's FREE daily newsletter. Email Address BCEL Media Mentions By Week BCEL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BCEL News Sentiment▼0.000.82▲Average Medical News Sentiment BCEL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BCEL Articles This Week▼00▲BCEL Articles Average Week Remove Ads Get Atreca News Delivered to You Automatically Sign up to receive the latest news and ratings for BCEL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AFMD News Today MRKR News Today SPRB News Today HCWB News Today IPA News Today CTXR News Today ATHA News Today BMRA News Today NERV News Today ORGS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BCEL) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atreca, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Atreca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
